TT Electronics to Spotlight its Radwave Technologies Collaboration at MD&M Minneapolis with Demo of New Electromagnetic Platform for Surgical Navigation

TT will also feature its core specialties for the medical device industry, including high reliability sensor, power and connectivity technologies, and global manufacturing

TT Electronics, a global provider of engineered technologies for performance-critical applications, will be exhibiting at MD&M Minneapolis 2021, November 3-4 in Minneapolis, Minnesota.

TT will showcase its collaboration with Radwave Technologies, bringing to market an innovative electromagnetic (EM) tracking platform for surgical navigation. The platform is customizable to enable accurate tracking of a broad spectrum of minimally invasive diagnostic and therapeutic devices during surgical procedures with no clear line of sight.

This advanced technology offers solutions for medical device innovators that are seeking to add new or improved EM capabilities to their medical products. Demonstrations will be available at TT’s booth #1608. TT will also highlight its core specialties, reflecting the company’s strategic focus on sustainability and developing technology solutions that enable a cleaner, smarter, healthier future:

●        Medical grade power supplies and solutions – reliable power conversion and management to drive product performance while maintaining efficiency and safety; these include miniaturized coils, transformers, and inductors uniquely developed for implantable devices and surgical navigation in clinical care, therapy and well-being, and home healthcare environments

●        Smart sensors and passive components – designed to capture data, inform decisions, support data analytics, and enable artificial intelligence; these include non-contact, Hall effect sensors, infrared optical switches and arrays for detection of objects or fluids, and fixed and variable resistors for current sensing, power management, and signal conditioning

●        Connectivity Solutions – built to connect, sense, track, and monitor, including wearable IoT devices, and wireless devices communicating over GSM and LTE Cat M1/NB-IoT for use in fast-paced healthcare and pharmaceutical environments

●        End-to-end, low-volume, high-mix global manufacturing in FDA-registered facilities – offerings span engineering, test development, system integration and fulfilment services for imaging/nuclear and monitoring equipment, diagnostic instruments, and cardiology and electrosurgical devices

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.